Common Contracts
1 similar Investment and Collaboration Agreement contracts
KalVista Get a Notable Investment and Collaboration AgreementInvestment and Collaboration Agreement • October 16th, 2017
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. The initial focus is on inhibitors of plasma kallikrein, which is an important component of the body's inflammatory response and which, in excess, can lead to increased vascular permeability, edema, and inflammation.
